Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06750549 · ClinicalTrials.gov registry record · NA
Mobile Application for Patient Engagement and Physician-Directed Remote Management of Heart Failure
A NA study of Heart Failure, sponsored by University of Michigan.
- Active
- Registry status
- NA
- Development phase
- 130
- Enrollment target
- 3
- Study locations
NCT06750549 is a NA study of Heart Failure that is active but no longer recruiting, run by University of Michigan. The registered enrollment target is 130 participants, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (94% lower). The trial reports 3 study locations across 3 states.
The verdict
NCT06750549, a NA study of Heart Failure, is active but no longer recruiting, sponsored by University of Michigan.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 130 participants
- Enrollment target
- 3
- Study locations
Study Summary
The ENGAGE-HF mobile application tracks three key features over time: (1) heart failure health status, (2) vital signs (e.g., blood pressure, heart rate) and weight, and (3) the quality of heart failure medication therapy. Helping patients understand how these characteristics interact and change over time may improve their ability to understand and manage heart failure. In this study, the investigators aim to evaluate whether the ENGAGE-HF mobile application, by facilitating the behavior change strategies of self-monitoring and feedback, and a clinician-facing dashboard, improves the optimization of heart failure guideline-directed medical therapies (GDMT) and quality of life. An optional sub-study of cognitive function will invite all eligible participants enrolled in the main study to participate.
Conditions Studied
Interventions
- DEVICE ENGAGE-HF Mobile Application
Study Locations (3)
California
- Stanford Cardiovascular Clinic - Stanford
Maryland
- The Johns Hopkins Hospital - Baltimore
Michigan
- U-M Frankel Cardiovascular Center - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 130 participants |
| Start Date | 2025-02-18 |
| Est. Completion | 2026-05-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06750549
The ClinicalTrials.gov registry entry for NCT06750549 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 130 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (94% lower). The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which ENGAGE-HF Mobile Application is the first listed.
NCT06750549 reports 3 study locations spanning 3 distinct geographic areas - top geographies include California, Maryland, Michigan.
Frequently Asked Questions
What is clinical trial NCT06750549 about?
NCT06750549 is a clinical study titled "Mobile Application for Patient Engagement and Physician-Directed Remote Management of Heart Failure". The ENGAGE-HF mobile application tracks three key features over time: (1) heart failure health status, (2) vital signs (e.g., blood pressure, heart rate) and weight, and (3) the quality of heart failure medication therapy. Helping patients understand how these characteristics interact and change ove...
What is the current status of trial NCT06750549?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 130 participants. The study started on 2025-02-18. Estimated completion is 2026-05-31.
What conditions does trial NCT06750549 study?
This clinical trial studies the following conditions: Heart Failure.
What interventions are being tested in trial NCT06750549?
The interventions under investigation include: ENGAGE-HF Mobile Application (DEVICE).
Who is sponsoring clinical trial NCT06750549?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06750549 being conducted?
This trial has 3 study locations across California, Maryland, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
Optimizing Heart Failure Therapies Among Patients With Limited Access in Denver
RECRUITING · NA
-
Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial
RECRUITING · NA
-
Effect of a Quality Improvement Initiative to Address Social Determinants of Health on Rehospitalization Rates in Patients With Heart Failure
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.